Krystal Biotech, Inc. (KRYS)

Krystal Biotech Revenue

Krystal Biotech had revenue of $116.36M in the quarter ending March 31, 2026, with 31.95% growth. This brings the company's revenue in the last twelve months to $417.30M, up 25.15% year-over-year. In the year 2025, Krystal Biotech had annual revenue of $389.13M with 33.94% growth.

• Revenue (ttm): $417.30M
• Revenue Growth: +25.15%
• P/S Ratio: 21.60
• Revenue / Employee: $1,414,590
• Employees: 295
• Market Cap: 9.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	389.13M	98.62M	33.94%
Dec 31, 2024	290.52M	239.82M	473.02%
Dec 31, 2023	50.70M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: May 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error